Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, BC AND BREDA, THE NETHERLANDS / ACCESS Newswire / January 2, 2026 / Organto Foods Inc. (TSX-V:OGO)(OTC ...

Vor Biopharma Inc. offers a high-risk, high-reward play on U.S. commercialization of telitacicept, a dual-target autoimmune drug approved in China. Complex warrant issuances and reverse stock split ...

The Honor Northwoods Flight is an organization that aims to send veterans to Washington D.C. in order to be able to see ...

The Nigerian Airspace Management Agency (NAMA) said flight delays, diversions and cancellations experienced during the ...

HALIFAX, NS / ACCESS Newswire / December 22, 2025 / Namibia Critical Metals Inc. ("Namibia Critical Metals" or the "Company" or "NMI") (TSXV:NMI)(OTCQB:NMREF) today announced that, it has received pro ...

By Chinelo Obogo‎‎The Nigerian Airspace Management Agency (NAMA) has said that all navigational aids (NAVAIDs) at the Federal Government airports across Nigeria are fully functional and compliant with ...

The Nigerian Airspace Management Agency (NAMA) has attributed flight delays, diversions and cancellations commonly ...

The Nigerian Airspace Management Agency (NAMA) has dismissed claims that its navigational aids are unfit or poorly maintained for Harmattan operations, insisting that all systems are fully serviceable ...

Vor Biopharma (VOR) has jumped onto investors’ radar after strong Phase 3 data for telitacicept in IgA nephropathy, paired with upbeat new Wall Street coverage that frames the drug’s long term ...

In recent months, Vor Biopharma closed a US$424.83 million shelf registration, repriced employee stock options, and reported positive late-stage clinical data for its autoimmune drug candidate ...

Vor Biopharma (VOR) rose ~17% on Tuesday after J.P. Morgan initiated its coverage with an Overweight recommendation and a Dec. 2026 price target of $43, citing a potential blockbuster status for the ...